Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applikon Biotechnology
Delft, Netherlandsapplicon.se ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Applikon Biotechnology is a leading provider of advanced bioreactor systems and online process analyzers supporting the development and manufacture of biologics, cell therapies, vaccines, and other life science products from laboratory scale to commercial production. The company was acquired by Getinge in January 2020, expanding its global reach while maintaining its focus on innovation in upstream biotechnology solutions.
- Modalities
- BiologicCell therapyVaccine
- Industry
- Non-Drug Biotech
02
Partnerships
GEA Diessel – strategic alliance for turn-key large-scale bio processing projects
Beyond the preview
Go deeper on Applikon Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Applikon Biotechnology.